Longevity News

A new off-ramp from Ozempic and Wegovy?

Source: Longevity Technology • Published: 15 Jun 2026, 16:41

A new off-ramp from Ozempic and Wegovy?

An endoscopic approach that aims to preserve weight after stopping GLP-1 therapy. Offers hopeful, cautious perspective for patients and clinicians.

Key Takeaways
  • Participants retained about 78% of prior GLP‑1 weight loss one year after one procedure
  • One third of participants continued losing weight after stopping GLP‑1 therapy
  • Subjects entered the study after averaging roughly 24% bodyweight reduction on GLP‑1 drugs
Read Original Source